Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2016 Volume 12 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2016 Volume 12 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells

  • Authors:
    • Venerando Rapisarda
    • Rossella Salemi
    • Andrea Marconi
    • Carla Loreto
    • Adriana C. Graziano
    • Venera Cardile
    • Maria S. Basile
    • Saverio Candido
    • Luca Falzone
    • Demetrios A. Spandidos
    • Concettina Fenga
    • Massimo Libra
  • View Affiliations / Copyright

    Affiliations: Section of Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, I-95124 Catania, Italy, Section of General and Clinical Pathology and Oncology, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95124 Catania, Italy, Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95124 Catania, Italy, Section of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95124 Catania, Italy, Department of Virology, Faculty of Medicine, University of Crete, 71003 Heraklion, Crete, Greece, Section of Occupational Medicine, Department of the Environment, Safety, Territory, Food and Health Sciences, University of Messina, I-98125 Messina, Italy
    Copyright: © Rapisarda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3363-3367
    |
    Published online on: August 26, 2016
       https://doi.org/10.3892/ol.2016.5051
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Exposure to asbestos is associated with the development of mesothelioma. In addition to asbestos, other fibers have been identified as risk factors for malignant and non-malignant diseases of the lungs. Among these, fluoro-edenite (FE) was found in patients from Biancavilla (Sicily, Italy) with pleural and lung disease, suggesting its role for tumor expansion. In this context, the identification of early biomarkers useful for the diagnosis of cancer is mandatory. Fibulin-3 represents an important marker for the diagnosis of mesothelioma. However, it remains to be determined whether it is directly associated with exposure to asbestos-like fibers. In the present study, peripheral blood levels of fibulin-3 from 40 asbestos-exposed workers were compared with those detected in 27 street cleaners from Biancavilla. Intriguingly, the results showed that fibulin-3 levels were higher in the group of street cleaners compared with those of the asbestos-exposed workers, suggesting that these workers used the personal protective equipment according to the current regulations. These data suggest that subjects exposed to FE should be monitored for the risk of mesothelioma. FE and volcanic particulates are probably contained within dust inhaled by street cleaners from Biancavilla during their work activities. Based on these criteria, in this study, such fibers were used to treat mesothelial cells (MeT5A) in order to verify whether fibulin-3 levels are affected by these treatments. The results showed that only treatment with FE was associated with fibulin-3 overexpression at both the transcript and protein levels. It was previously demonstrated that mesothelial cells exhibited low levels of p27 following treatment with FE. Notably, p27 downregulation is associated with stathmin upregulation in cancer, conferring an aggressive phenotype of tumor cells. This observation prompted us to perform a computational evaluation demonstrating the activation of stathmin in lung cancer in patients exposed to asbestos. Overall, it can be speculated that both fibulin-3 and stathmin overexpression may be associated with the malignant transformation of mesothelial cells following exposure to asbestos-like fibers.

Introduction

Asbestos has been widely used in many industrial contexts for its extraordinary thermal insulation properties. Over the past years, millions of tons of asbestos have been processed worldwide. The most common asbestos used is the chrysotile (white asbestos), followed by amphibolic asbestos (blue and brown asbestos). However, their toxic effects have been known for 50 years (1).

It is already known that asbestos inhalation can induce the development of mesothelioma and several other cancer types, included that of the lung. Specifically, the risk of developing lung cancer has been suggested to be related to the cumulative exposure to asbestos, with an estimated increase in risk of 1% for each fiber/ml-year of exposure (2). It has also been observed that exposure to asbestos may be associated with non-neoplastic diseases, such as asbestosis and pleural fibrosis (3). The interval between first exposure and the development of mesothelioma ranges from 20 to 60 years (4). The highest worldwide incidence is estimated occur in the year 2020 (5).

Individuals who are at risk are those who have previously worked in shipbuilding industries, railway construction companies and asbestos-cement industries; however, due to the spread of asbestos shipyards, home improvements and many other types of uncontrolled construction work, a larger number of cases have been identified among building craftsmen exposed accidentally and often unknowingly. Moreover, unwitting victims of asbestos are the wives and children of workers who carry home asbestos dust on their clothes. The difficulty of removing asbestos already in place represents an additional risk for the development of mesothelioma and lung cancer (2,6).

Health surveillance in workers exposed to asbestos is focused on the early detection of the major diseases related to asbestos (7). Unfortunately, the health surveillance protocols adopted for workers exposed to asbestos do not meet the requirements of sensitivity and specificity required to ensure early diagnosis (8). Additionally, apart from asbestos fibers, it has been demonstrated that other fibers, such as fluoro-edenite (FE), may have toxic effects (9).

Therefore, there is an urgent need to identify novel markers useful for the early diagnosis of asbestos and asbestos-like fibers-associated diseases. Although it has been demonstrated that fibulin-3 is an important marker used for the diagnosis of mesothelioma (10), its role in the early stage of the disease is still under debate.

High circulating levels of fibulin-3 have been observed in street cleaners from Biancavilla (Sicily, Italy), which are at high risk of FE exposure, when comparing their pleural plaques with those of a non-exposed control group (11–13). However, if such an overexpression is due to the exposure of asbestos-like fibers or to other environmental factors, such as volcanic particulates, remains to be further clarified.

On the basis of these criteria, in the present study, we analyzed circulating levels of fibulin-3 in individuals exposed to asbestos and compared with them with those previously detected in workers exposed to FE. Furthermore, in vitro experiments using mesothelial cells (Met5A) were performed to determine whether the expression of fibulin-3 correlates with the exposure to asbestos-like fibers and/or other particulates.

Materials and methods

Subjects

The subjects enrolled in the present study included 40 workers exposed to asbestos fibers, including 30 removal and disposal workers and 10 coating workers, employed in old pipeline maintenance. Ten healthy subjects were also included as controls. The subjects and healthy controls included in this study were recruited at the Occupational Medicine Unit, School of Medicine, University of Catania, Catania, Italy. They comprised both categories of workers, those exposed to asbestos fibers (cases) and those without such exposure working in different places (healthy subjects or controls). All study participants provided a written informed consent. The study was approved by the University of Catania Ethics Committee.

Information on occupational history, socio-demographic indicators, smoking habits and clinical history were collected using validated questionnaires. Briefly, all subjects (workers) were male, with a mean age of 52 years; 30 out of 40 were smokers; the mean duration of exposure to asbestos was 14 years. All healthy subjects were male with a mean age of 50 years and all of them were smokers. The participants underwent blood testing, spirometry, physical examination and chest high-resolution computed tomography (HRCT).

Blood samples were collected into EDTA plasma tubes and processed within 2 h. The samples were centrifuged at 950 × g for 10 min and the supernatant was aliquoted and stored at −80°C until analysis.

Enzyme-linked immunosorbent assay (ELISA). Fibulin-3 plasma levels were determined in the 40 cases and in 10 controls in duplicate using a human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) ELISA kit (Cusabio Biotech Co., Ltd., College Park, MD, USA) according to the manufacturer's instructions. Plasma samples were diluted and the immunoassay was carried out according to the manufacturer's instructions. Marker concentrations for each sample were calculated from the standard curve. All tests were assayed in duplicate. A subset of samples was assayed 4 times in each ELISA plate for quality control. No significant cross-reactivity to or interference with various proteins was observed. The optical density was measured at 450 nm using a microplate reader (Tecan ELISA Reader; Tecan Group Ltd., Männedorf, Switzerland). The results were compared with those obtained from the 27 street cleaners exposed to carcinogenic fibers analyzed in our previous study (11).

Cell culture and treatment

The non-malignant transformed human pleural mesothelial cell line (Met-5A) was obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA) and cultured in RPMI-1640 medium, supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin (all from Lonza, Walkersville, MD, USA) and incubated at 37°C in humidified atmosphere with 5% CO2.

The cells were plated at a density of 120,000 cells/well in a 6-well dish in a final volume of 2 ml per well, and exposed to various concentrations of FE and A, B, C and D volcanic particulates (10, 50 and 100 µg/ml) for 72 h. MeT5A cells grown in normal medium were used as controls. Subsequently the cells were deprived of culture medium and washed in phosphate-buffered saline (PBS), then collected in tubes and centrifuged at 250 × g for 5 min at 4°C. The pellets thus obtained were stored at −80°C before being used for protein and RNA extraction. All treatments were performed in triplicate.

FE fibers were collected in the area of Biancavilla (Sicily) and then characterized. The volcanic particulates [A (basalt residues), B (volcanic ash), C (mixed basalt and cement) and D (cement)], were collected in different areas of Mount Etna (Sicily, Italy) and underwent physical and chemical characterizations, as previously described (14). All particles were suspended in RPMI-1640 medium to yield stock solutions.

Reverse transcription-quantitative (real-time) PCR (RT-qPCR)

Total RNA was isolated from the cell pellets using an extraction kit (PureLink RNA mini kit; Ambion/Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions. First-strand cDNA was reverse transcribed with 1 µg of total RNA. The resultant cDNA was then used for quantitative PCR (qPCR) reactions, which were performed using the Applied Biosystems 7300 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA).

The fibulin-3 primer sequences were as follows: 5′-CGAGGGGAGCAGTGCGTAGACATAG-3′ (sense) and 5′-CTTCACAGTTGAGCCTGTCACTGCT-3′ (antisense). The housekeeping gene, phosphoglycerate kinase 1 (PGK1), was used as an internal control for normalization of the results. The PGK1 primer sequences were as follows: 5′-TTAAAGGGAAGCGGGTCGTT-3′ (sense) and 5′-CAGGCATGGGCACACCAT-3′ (antisense).

The amplification of fibulin-3 and PGK1 was performed with 1 cycle at 95°C for 10 min, and 40 cycles at 95°C for 15 sec and 60°C for 1 min. The calculation of the relative expression of each transcript was performed using the 2−ΔΔCt method.

Western blot analysis

The cells were lysed in NP-40 cell lysis buffer (50 mM Tris pH 7.4, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1 mM Na3VO4, 1% Nonidet P-40, 0.02% NaN3) containing a protease inhibitor cocktail (Sigma, St. Louis, MO, USA). The extracted protein amounts were quantified using the Quick Start™ Bradford 1X Dye Reagent assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Equivalent amounts of protein (40 µg) were separated using Mini Protean TGX Precast Gels (Bio-Rad Laboratories, Inc.; 4–15%) and transferred onto a PVDF/nitrocellulose membrane (Bio-Rad Laboratories, Inc.). Western blot analysis was performed using the following primary antibodies: EFEMP1 (PA5-26104) (Thermo Fisher Scientific, Waltham, MA, USA) and β-tubulin (ab15568) (Abcam, Cambridge, UK). The western blot analysis signal was detected using the ChemiDoc Touch Imaging system (Bio-Rad Laboratories, Inc.). The densitometry of the western blot analysis results was measured using ImageJ software (National Institutes of Health, Bethesda, MD, USA).

Computational analysis of stathmin 1

To determine whether stathmin 1 overexpression is associated with exposure to asbestos, datasets of gene expression profiling available on the Gene Expression Omnibus (GEO) dataset (www.ncbi.nlm.nih.gov/geo/) were analyzed. Among all publically available GEO datasets, only those containing lung cancer or mesothelioma samples with stathmin 1 expression levels, clinical data relative to asbestos exposure were analyzed. Based on these criteria, only the GSE23822 dataset (15) was used for our analysis. This dataset includes 26 samples of lung cancer with confirmed asbestos exposure and 30 non-exposed samples.

No additional normalization procedure was applied. Differential analysis of stathmin 1 expression levels between the exposed and non-exposed groups was performed using the Student's t-test.

Statistical analysis

Statistical analysis of fibulin-3 expression in the plasma samples was performed using Kruskal-Wallis test. The analysis of the expression levels of EFEMP1 in the cells was obtained using the Student's t-test. A value of p<0.05 (by a two-tailed test) was considered to indicate a statistically significant difference.

Odds ratios (OR) and the corresponding 95% confidence intervals (CI) were calculated by means of multiple logistic regression models including terms for gender, age and smoking habits. The test for trend was based on the likelihood-ratio test between the models with and without linear terms for each variable of interest. The attributable risk percent values were computed as previously described (16). All statistical analyses were performed using SAS 9.2 statistical software (SAS Institute, Cary, NC, USA).

Results

Both groups of asbestos workers (disposal and coating) enrolled in this study did not report a diagnosis of mesothelioma or other pulmonary diseases (asbestosis and/ or pleural plaques); only 7 workers exhibited an allergy to pollen and/or dust and 30 out of the 40 workers were smokers. The mean values (% predicted) of the functional respiratory tests were within the normal range for both groups. Blood parameters were in the normal range (data not shown).

Analysis of fibulin-3 in workers

The median plasma levels of fibulin-3 were 1.51 ng/ml (0.46–3.978) and 1.73 ng/ml (1.012–3.59) in the removal/disposal and coating worker groups, respectively. These results were similar to those detected in the normal samples. However, statistical differences were observed when we compared these data with those obtained from the plasma of workers occupationally exposed to carcinogenic fibers previously analyzed (11) (Fig. 1). No association between fibulin-3 plasma levels and the duration of exposure to asbestos or the radiographic score was observed in these subjects. The fibulin-3 plasma levels were also not influenced by the age, gender or smoking habits of the subjects (data not shown).

Figure 1.

Circulating plasma levels of fibulin-3 in asbestos-exposed workers. The data for the street cleaners (EFEMP-1, fibulin-3) were from a previous study (10). *p<0.05.

Expression of fibulin-3 detected at the transcript and protein levels in MeT5A cells

The fibulin-3 protein and mRNA levels were evaluated in the MeT5A cells incubated with 10, 50 and 100 µg/ml of FE fibers and A, B, C and D volcanic particulates for 72 h. As shown in Fig. 2A, a marked increase in fibulin-3 protein expression was observed in the MeT5A cells exposed to FE compared with the controls. However, the cells exposed to the A, B, C and D volcanic particulates did not exhibit any significant increase in fibulin-3 expression (data not shown).

Figure 2.

Fibulin-3 expression levels in mesothelial Met5A cell lines following exposure to various concentrations of fluoro-edenite fibers detected at the (A and B) protein and (C) transcript levels. *p<0.05 compared to controls.

As shown in Fig. 2B, the MeT5A cells exhibited higher protein levels of fibulin-3 following exposure to FE at the concentrations of 50 and 100 µg/ml (p<0.05), compared with the controls; however, exposure of the cells to 10 µg/ml of FE did not lead to any significant changes in fibulin-3 protein expression compared with the untreated MeT5A cells.

mRNA fibulin-3 overexpression was detected in the cells exposed to each of the three concentrations of fluoro-edenite (Fig. 2C). Similar to the results obtained for the protein levels the cells exposed to the A, B, C and D volcanic particulates did not exhibit any significant increase in mRNA fibulin-3 expression (data not shown).

Computational analysis of stathmin 1

A publically available dataset of 56 lung cancer samples was analyzed for the expression of stathmin 1. This dataset comprised 26 tumor samples from lung cancer patients with a history of exposure to asbestos. The transcript levels of stathmin were significantly higher in the group of tumors derived from patients exposed to asbestos compared with the other group not exposed to asbestos (Fig. 3).

Figure 3.

Differences of STMN1 transcript levels detected in lung cancers diagnosed in exposed and non-exposed to asbestos patients according to the dataset described in the study by Wright et al (14). STMN1, stathmin 1.

Discussion

FE, a mineral from the calcic clino-amphibole subgroup, was found in the sputum of subjects from Biancavilla, a city in Eastern Sicily, and in lung specimens from sheep living nearby (12,13,17). In particular, various types of airborne asbestos-like mineral fibers were identified in the volcanic area of Mount Etna and may represent the cause of the increased incidence of mesothelioma and lung cancer and other lung diseases (18). As far back as 1987, the International Agency of Research on Cancer emphasized that the vast majority of asbestos-induced diseases are caused by occupational exposure, as well as non-occupational asbestos exposure (19,20). Starting from in the mid-1970s, the discovery of sites of endemic mesothelioma in some rural areas (Turkey, Greece, Cyprus, Corsica, and more recently, New Caledonia, Sicily, China and California) has provided important information about the carcinogenicity of various mineral fibers (6,21).

In the present study, for the first time, at least to the best of our knowledge, the expression levels of fibulin-3 in normal mesothelial cells following exposure to both FE and other volcanic particulates were analyzed. These data strongly support the notion that fibulin-3 in mesothelial cells is activated following exposure to FE and not following exposure to the other particulates. These results suggest the potential role of fibulin-3 in the development of neoplastic and non-neoplastic diseases of the respiratory tract in subjects exposed to FE (11).

Surprisingly, we also observed that the plasma levels of fibulin-3 were significantly lower in the group of workers exposed to asbestos fibers compared to those previously observed exposed to FE (11). These findings suggest that asbestos disposal workers properly used the personal protective equipment (PPE) according to the current regulations. By contrast, other workers, such as street cleaners should be better equipped to prevent injury caused exposure to FE (11). According to this observation, our in vitro experiments indicated that fibulin-3 was overexpressed in mesothelial cells following exposure to FE and not following exposure to volcanic particulates. These data were observed at both the transcript and protein levels. Therefore, we can argue that the detection of high plasma levels of fibulin-3, observed in street cleaners from the Biancavilla area, may be due to FE exposure (11). However, exposure to volcanic particulates did not affect fibulin-3 expression. These data may be in agreement with those of a previous study demonstrating the high incidence of mesotheliomas in the area of Biancavilla associated with exposure to FE (18).

Overall, our data support the notion that the increased levels of fibulin-3 are associated most likely with an inflammatory mechanism caused by exposure to FE (22). Furthermore, these data indicate that the subset of subjects exposed to FE has to be monitored for the development of mesothelioma. Accordingly, it is already known that chronic exposure to asbestos-like fibers may cause chronic inflammation and cancer. Such chronic inflammation is associated with the production of several cytokines and growth factors that may cause cellular proliferation and apoptosis arrest (9,22). On this matter, it has been shown that p27 is downregulated in mesothelial cells following exposure to FE fibers (23). Notably, p27 is considered a tumor suppressor gene due to its function as a regulator of the cell cycle, and in cancers it is often inactivated (24). It has also been demonstrated that low levels of p27 are associated with stathmin upregulation, determining an aggressive phenotype of tumor cells (25). Of note, we have previously demonstrated that stathmin expression is useful for the survival of cancer cells carrying a p53 mutant (26) that may be also involved in the drug resistance mechanisms of hematopoietic cells (27). On this ground, we performed a bioinformatic evaluation to determine whether stathmin is involved in the malignant transformation associated with exposure to asbestos-like fibers. This computational approach showed the overexpression of stathmin in the group of 26 lung cancer patients with a history of asbestos exposure compared with those not exposed to any fibers. According to these data, we can speculate that both fibulin-3 overexpression and stathmin activation may be responsible for the malignant transformation of mesothelial cells following exposure to asbestos-like fibers.

References

1 

Wagner JC, Sleggs CA and Marchand P: Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 17:260–271. 1960.PubMed/NCBI

2 

Boffetta P: Health effects of asbestos exposure in humans: a quantitative assessment. Med Lav. 89:471–480. 1998.PubMed/NCBI

3 

International Agency for Research on Cancer, . Asbestos (Chrysolite, Amosite, Crocidolite, Tremolite, Actinolite, and Anthophyllite)IARC Monographs. Arsenic, Metals, Fibres and Dusts. International Agency for Research on Cancer; Lyon: pp. 147–167. 2009

4 

Tan C and Treasure T: Mesothelioma: time to take stock. J R Soc Med. 98:455–458. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Robinson BW and Lake RA: Advances in malignant mesothelioma. N Engl J Med. 353:1591–1603. 2005. View Article : Google Scholar : PubMed/NCBI

6 

McDonald JC and McDonald AD: The epidemiology of mesothelioma in historical context. Eur Respir J. 9:1932–1942. 1996. View Article : Google Scholar : PubMed/NCBI

7 

Crisstaudo A, Foddis R and Guglielmi G: Methodology and results of an experience of medical surveillance of people previously exposed to asbestos in Tuscany. G Ital Med Lav Ergon. 32(Suppl 4): 385–388. 2010.(In Italian). PubMed/NCBI

8 

Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF and Prorok PC: Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 92:1308–1316. 2000. View Article : Google Scholar : PubMed/NCBI

9 

Loreto C, Rapisarda V, Carnazza ML, Musumeci G, Valentino M, Fenga C and Martinez G: Fluoro-edenite fibres induce lung cell apoptosis: an in vivo study. Histol Histopathol. 23:319–326. 2008.PubMed/NCBI

10 

Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, et al: Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med. 367:1417–1427. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Rapisarda V, Ledda C, Migliore M, Salemi R, Musumeci A, Bracci M, Marconi A, Loreto C and Libra M: FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: a pilot study. Future Oncol. 11(Suppl 24): 35–37. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Bruni BM, Pacella A, MazziottiTagliani S, Gianfagna A and Paoletti L: Nature and extent of the exposure to fibrous amphiboles in Biancavilla. Sci Total Environ. 370:9–16. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Putzu MG, Bruno C, Zona A, Massiccio M, Pasetto R, Piolatto PG and Comba P: Fluoro-edenitic fibres in the sputum of subjects from Biancavilla (Sicily): a pilot study. Environ Health. 5:202006. View Article : Google Scholar : PubMed/NCBI

14 

Ledda C, Rapisarda V, Bracci M, Proietti L, Zuccarello M, Fallico R, Fiore M and Ferrante M: Professional exposure to basaltic rock dust: assessment by the Vibrio fischeri ecotoxicological test. J Occup Med Toxicol. 8:232013. View Article : Google Scholar : PubMed/NCBI

15 

Wright CM, Francis SM Savarimuthu, Tan ME, Martins MU, Winterford C, Davidson MR, Duhig EE, Clarke BE, Hayward NK, Yang IA, et al: MS4A1 dysregulation in asbestos-related lung squamous cell carcinoma is due to CD20 stromal lymphocyte expression. PLoS One. 7:e349432012. View Article : Google Scholar : PubMed/NCBI

16 

Polesel J, Franceschi S, Talamini R, Negri E, Barzan L, Montella M, Libra M, Vaccher E, Franchin G, La Vecchia C and Serraino D: Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population. Oral Oncol. 47:541–545. 2011. View Article : Google Scholar : PubMed/NCBI

17 

De Nardo P: More attention to veterinarian epidemiologists. Epidemiol Prev. 28:1942004.(In Italian). PubMed/NCBI

18 

Paoletti L, Batisti D, Bruno C, Di Paola M, Gianfagna A, Mastrantonio M, Nesti M and Comba P: Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: an epidemiological and environmental study. Arch Environ Health. 55:392–398. 2000. View Article : Google Scholar : PubMed/NCBI

19 

International Agency for Research on Cancer, . IARC Monographs on the evaluation of carcinogenic risks to humans. Supplement 7:1-42. IARC Press; Lyon: 1987

20 

Committee on Asbestos: Selected Health Effects; Board on Population Health and Public Health Practices; Institute of Medicine, . Asbestos: Selected Cancers. The National Academies Press; Washington, DC: 2006

21 

Goldberg M and Luce D: The health impact of nonoccupational exposure to asbestos: what do we know? Eur J Cancer Prev. 18:489–503. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Cardile V, Lombardo L, Belluso E, Panico A, Renis M, Gianfagna A and Balazy M: Fluoro-edenite fibers induce expression of Hsp70 and inflammatory response. Int J Environ Res Public Health. 4:195–202. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Musumeci G, Cardile V, Fenga C, Caggia S and Loreto C: Mineral fibre toxicity: Expression of retinoblastoma (Rb) and phospho-retinoblastoma (pRb) protein in alveolar epithelial and mesothelial cell lines exposed to fluoro-edenite fibres. Cell Biol Toxicol. 27:217–225. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Chu IM, Hengst L and Slingerland JM: The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V and Colombatti A: p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell. 7:51–63. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Sonego M, Schiappacassi M, Lovisa S, Dall'Acqua A, Bagnoli M, Lovat F, Libra M, D'Andrea S, Canzonieri V, Militello L, et al: Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer. EMBO Mol Med. 5:707–722. 2013. View Article : Google Scholar : PubMed/NCBI

27 

McCubrey JA, Abrams SL, Ligresti G, Misaghian N, Wong EW, Steelman LS, Bäsecke J, Troppmair J, Libra M, Nicoletti F, et al: Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. Leukemia. 22:2080–2090. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Rapisarda V, Salemi R, Marconi A, Loreto C, Graziano AC, Cardile V, Basile MS, Candido S, Falzone L, Spandidos DA, Spandidos DA, et al: Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells. Oncol Lett 12: 3363-3367, 2016.
APA
Rapisarda, V., Salemi, R., Marconi, A., Loreto, C., Graziano, A.C., Cardile, V. ... Libra, M. (2016). Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells. Oncology Letters, 12, 3363-3367. https://doi.org/10.3892/ol.2016.5051
MLA
Rapisarda, V., Salemi, R., Marconi, A., Loreto, C., Graziano, A. C., Cardile, V., Basile, M. S., Candido, S., Falzone, L., Spandidos, D. A., Fenga, C., Libra, M."Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells". Oncology Letters 12.5 (2016): 3363-3367.
Chicago
Rapisarda, V., Salemi, R., Marconi, A., Loreto, C., Graziano, A. C., Cardile, V., Basile, M. S., Candido, S., Falzone, L., Spandidos, D. A., Fenga, C., Libra, M."Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells". Oncology Letters 12, no. 5 (2016): 3363-3367. https://doi.org/10.3892/ol.2016.5051
Copy and paste a formatted citation
x
Spandidos Publications style
Rapisarda V, Salemi R, Marconi A, Loreto C, Graziano AC, Cardile V, Basile MS, Candido S, Falzone L, Spandidos DA, Spandidos DA, et al: Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells. Oncol Lett 12: 3363-3367, 2016.
APA
Rapisarda, V., Salemi, R., Marconi, A., Loreto, C., Graziano, A.C., Cardile, V. ... Libra, M. (2016). Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells. Oncology Letters, 12, 3363-3367. https://doi.org/10.3892/ol.2016.5051
MLA
Rapisarda, V., Salemi, R., Marconi, A., Loreto, C., Graziano, A. C., Cardile, V., Basile, M. S., Candido, S., Falzone, L., Spandidos, D. A., Fenga, C., Libra, M."Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells". Oncology Letters 12.5 (2016): 3363-3367.
Chicago
Rapisarda, V., Salemi, R., Marconi, A., Loreto, C., Graziano, A. C., Cardile, V., Basile, M. S., Candido, S., Falzone, L., Spandidos, D. A., Fenga, C., Libra, M."Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells". Oncology Letters 12, no. 5 (2016): 3363-3367. https://doi.org/10.3892/ol.2016.5051
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team